Dr. Westrup is the Director of Oncology, and a Consultant Medical Oncologist at Beacon Hospital. She is appointed Associate Clinical Professor at University College Dublin (UCD) and sits on the steering committee of the innovative UCD Beacon Academy. Dr. Westrup is the former Medical Director at Beacon Hospital.
Dr. Westrup joined Beacon Hospital in 2007 as the first full-time Medical Oncologist and was appointed the Section Chief of Oncology.
Dr. Westrup was a member of the original Beacon Hospital Board from 2007 – 2008, served as Chairperson of the Beacon Pharmacy/Therapeutics Committee for 3 years, and as the Director of Education for Beacon Hospital from 2008 – 2014.
She currently sits on the Clinical Governance Committee of Beacon Hospital’s Board and lectures on the UCD Risk Management Program.
Dr. Westrup is a member of Cancer Trials Ireland. Her past research on breast cancer has been presented at international conferences, and is published in peer reviewed journals. Dr. Westrup currently advises the Health Care Products Regulatory Clinical Sub Trials Committee. She is a member of the National Cancer Care Program, Melanoma Clinical Advisory Group.
Dr. Westrup graduated Cum Laude from Wake Forest University with a BSc in Biology and received her medical degree with honours at University College Dublin. She completed an Internal Medicine Residency at Boston University Medical Center, was Resident Teacher of the Year and awarded the CREST scholarship; a National Institute of Health Grant. She completed a fellowship in Hematology/Oncology at Boston University Medical Center and was honoured as Chief Fellow. Dr. Westrup is American Board Certified in Internal Medicine and Medical Oncology.
Dr Ray McDermott, Consultant Medical Oncologist, MB BCh BAO PhD MBA MRCPI.
Dr Ray McDermott commenced his training in Medical Oncology at the Mater Hospital, Dublin during which time he completed an MBA in Health Services Management. He went on to The Institut Curie, Paris (2000-2002) where he completed a PhD in Tumour Immunology. He subsequently completed his clinical training at Fox Chase Cancer Center, Philadelphia (2002-2004), where he furthered an interest in Genito-Urinary Oncology. During this training period, he published over twenty peer reviewed articles and Book Chapters. He took up a post as Consultant Medical Oncologist at the Adelaide Meath & National Childrens Hospital, Tallaght in July 2004.
In 2006, Dr McDermott was instrumental in establishing Ireland as a main member of the Eastern Co-Operative Group, the largest clinical trials group in the USA with over 70 active studies. Dr McDermott is the Principal Investigator for Ireland in this initiative and is involved in twice yearly meetings with ECOG to develop this relationship. Dr McDermott is currently Vice-Chair of ICORG, the Irish Clinical Oncology Research Group. Under the auspices of the National Cancer Control Programme and the establishment of ‘Centres of Excellence’, Dr McDermott’s public hospital commitment has recently been split between AMNCH and St Vincent’s University Hospital, where he pursues his interest in genito-urinary and pancreas cancers. Along with Dr Jennifer Westrup, he has been involved in the establishment and growth of the cancer services at Beacon. – See more at: https://www.beaconhospital.ie/doctors/dr-ray-mcdermott/#sthash.iZoC9uGy.dpuf